BioSpace News Archive

Hansa Medical AB to Change Name to Hansa Biopharma AB

Nname change resolutions approved at an Extraordinary General Meeting (“EGM”) held on December 4, 2018, have been approved by the ‘Bolagsverket’ in Sweden.

December 20, 2018
·
1 min read
Business

Altria-Juul Deal Is Alarming Development for Public Health and Shows Need for Strong FDA Regulation

Statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids

December 20, 2018
·
2 min read
Drug Development

Omeros Establishes Independent Academic Leadership Committee for its OMS721 Phase 3 Clinical Program in IgA Nephropathy

Committee is Comprised of World Leaders in IgA Nephropathy and Renal Clinical Research

December 20, 2018
·
9 min read
Ayala Pharmaceuticals Signs Deal to Develop and Commercialize AL102 in Combination with BCMA Targeting Agents in Multiple Myeloma

Licensing agreement includes equity investment and potential development, clinical, regulatory and commercial milestones and tiered royalties

December 20, 2018
·
2 min read
Devonian Health Group Announces 2018 Annual General Shareholder’s Meeting

Shareholders should expect to receive the company’s proxy statement and related materials in early January 2019.

December 20, 2018
·
3 min read
Business

Healthy Mom And Baby Resolutions For The New Year: March Of Dimes Offers Tips For Planning A Pregnancy

For women thinking of having a baby in the coming year, making a resolution to be as healthy as possible before conception will increase the likelihood of having a healthy pregnancy and baby, says March of Dimes, the leader in the fight for moms and babies.

December 20, 2018
·
2 min read
Pharm Country

Deborah Heart and Lung Center among Top 7% in the Nation for Heart Surgery

Deborah Heart and Lung Center is among the top 7% in the nation for heart surgery, as rated by the Society of Thoracic Surgeons (STS).

December 20, 2018
·
2 min read
Policy

Propanc Biopharma’s Foundation Patent Granted in India

Pioneering Patent Covers Novel Cancer Treatments, Achieves New Company Milestone

December 20, 2018
·
5 min read
Drug Development

CEL-SCI Reports Fiscal 2018 Financial Results and Clinical & Corporate Developments

CEL-SCI Corporation reported financial results for the fiscal year ended September 30, 2018

December 20, 2018
·
7 min read
BioMidwest

Bio-Techne To Present At The 37th Annual J.P. Morgan Healthcare Conference

Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9th, 2019,

December 20, 2018
·
2 min read